HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expanding Donor Options for Lung Transplant: Extended Criteria, Donation After Circulatory Death, ABO Incompatibility, and Evolution of Ex Vivo Lung Perfusion.

Abstract
Only using brain-dead donors with standard criteria, the existing donor shortage has never improved in lung transplantation. Currently, clinical efforts have sought the means to use cohorts of untapped donors, such as extended criteria donors, donation after circulatory death, and donors that are ABO blood group incompatible, and establish the evidence for their potential contribution to the lung transplant needs. Also, technical maturation for using those lungs may eliminate immediate concerns about the early posttransplant course, such as primary graft dysfunction or hyperacute rejection. In addition, recent clinical and preclinical advances in ex vivo lung perfusion techniques have allowed the safer use of lungs from high-risk donors and graft modification to match grafts to recipients and may improve posttransplant outcomes. This review summarizes recent trends and accomplishments and future applications for expanding the donor pool in lung transplantation.
AuthorsKentaro Noda, Masashi Furukawa, Ernest G Chan, Pablo G Sanchez
JournalTransplantation (Transplantation) Vol. 107 Issue 7 Pg. 1440-1451 (07 01 2023) ISSN: 1534-6080 [Electronic] United States
PMID36584375 (Publication Type: Review, Journal Article)
CopyrightCopyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Topics
  • Humans
  • Tissue and Organ Procurement
  • Tissue Donors
  • Lung (surgery)
  • Lung Transplantation (adverse effects, methods)
  • Blood Group Incompatibility
  • Perfusion (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: